Best Penny Stocks Under 25 Cents Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.25 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.25. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Nikola NASDAQ:NKLA$0.18 -0.07 (-28.74%) Closing price 02/25/2025Extended Trading$0.18 0.00 (0.00%) As of 02/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions in the United States and internationally. More about NikolaMarket Capitalization$11.14 millionP/E Ratio-0.01Consensus RatingHoldConsensus Price Target$12.00 (+6,457.4% Upside)Volume36.66 million sharesAverage Volume8.19 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Syros Pharmaceuticals NASDAQ:SYRS$0.06 -0.04 (-41.43%) As of 03/21/2025 03:59 PM EasternSyros Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. More about Syros PharmaceuticalsMarket Capitalization$1.65 millionP/E Ratio-0.02Consensus RatingHoldConsensus Price Target$3.33 (+5,320.1% Upside)Volume2.90 million sharesAverage Volume8.06 million shares3. IN8bio NASDAQ:INAB$0.23 0.00 (-0.09%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$0.23 0.00 (-0.73%) As of 03/21/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IN8bio, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. More about IN8bioMarket Capitalization$18.91 millionP/E Ratio-0.31Consensus RatingBuyConsensus Price Target$6.00 (+2,478.4% Upside)Volume621,108 sharesAverage Volume1.84 million shares4. Lyra Therapeutics NASDAQ:LYRA$0.18 +0.01 (+5.04%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$0.18 +0.00 (+0.57%) As of 03/21/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lyra Therapeutics, Inc, a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. More about Lyra TherapeuticsMarket Capitalization$11.53 millionP/E Ratio-0.12Consensus RatingHoldConsensus Price Target$4.50 (+2,471.4% Upside)Volume844,723 sharesAverage Volume1.90 million shares5. Omega Therapeutics NASDAQ:OMGA$0.12 -0.03 (-21.83%) Closing price 02/24/2025Extended Trading$0.12 0.00 (0.00%) As of 02/24/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Omega Therapeutics, Inc operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. More about Omega TherapeuticsMarket Capitalization$6.92 millionP/E Ratio-0.09Consensus RatingModerate BuyConsensus Price Target$9.20 (+7,260.0% Upside)Volume4.81 million sharesAverage Volume2.61 million shares6. Bio-Path NASDAQ:BPTH$0.16 -0.02 (-10.69%) As of 03/21/2025 02:18 PM EasternBio-Path Holdings, Inc operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. More about Bio-PathMarket Capitalization$1.29 millionConsensus RatingBuyConsensus Price Target$20.00 (+12,770.0% Upside)Volume19,022 sharesAverage Volume1.62 million sharesToday's Range$0.15▼$0.18Remove Ads7. Allakos NASDAQ:ALLK$0.25 0.00 (-0.56%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$0.25 +0.00 (+0.48%) As of 03/21/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Allakos Inc, a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. More about AllakosMarket Capitalization$22.53 millionP/E Ratio-0.12Consensus RatingHoldConsensus Price Target$2.00 (+700.6% Upside)Volume389,205 sharesAverage Volume991,580 shares8. Wag! Group NASDAQ:PET$0.25 +0.01 (+4.59%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$0.24 -0.01 (-2.15%) As of 03/21/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Wag! Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent pet caregivers to connect with pet parents. More about Wag! GroupMarket Capitalization$12.26 millionP/E Ratio-0.63Consensus RatingModerate BuyConsensus Price Target$4.90 (+1,889.4% Upside)Volume103,665 sharesAverage Volume864,911 shares9. Gryphon Digital Mining NASDAQ:GRYP$0.19 0.00 (-1.82%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$0.20 +0.01 (+3.40%) As of 03/21/2025 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Gryphon Digital Mining, Inc operates as a bitcoin mining company in the United States. It operates mining computers and ESG-led mining. More about Gryphon Digital MiningMarket Capitalization$10.07 millionConsensus RatingHoldVolume370,887 sharesAverage Volume1.05 million sharesToday's Range$0.19▼$0.2150-Day Range$0.19▼$0.4410. P3 Health Partners NASDAQ:PIII$0.17 +0.00 (+1.24%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$0.17 0.00 (-0.58%) As of 03/21/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. More about P3 Health PartnersMarket Capitalization$61.72 millionP/E Ratio-0.20Consensus RatingHoldConsensus Price Target$0.25 (+45.3% Upside)Volume182,559 sharesAverage Volume974,708 shares11. Aspira Women's Health NASDAQ:AWH$0.09 -0.01 (-12.10%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$0.09 +0.01 (+6.48%) As of 03/21/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aspira Women's Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. More about Aspira Women's HealthMarket Capitalization$1.55 millionP/E Ratio-0.07Consensus RatingModerate BuyConsensus Price Target$4.40 (+4,905.7% Upside)Volume2.40 million sharesAverage Volume1.07 million sharesRemove Ads12. Solo Brands NYSE:DTC$0.21 0.00 (-0.10%) Closing price 03/21/2025 03:58 PM EasternExtended Trading$0.20 0.00 (-1.91%) As of 03/21/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Solo Brands, Inc operates a direct-to-consumer platform that offers outdoor and lifestyle branded products in the United States. More about Solo BrandsMarket Capitalization$19.16 millionP/E Ratio-0.06Consensus RatingHoldConsensus Price Target$1.18 (+462.2% Upside)Volume999,906 sharesAverage Volume411,968 shares13. Cutera NASDAQ:CUTR$0.04 -0.07 (-63.86%) Closing price 03/12/2025Extended Trading$0.04 0.00 (0.00%) As of 03/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. More about CuteraMarket Capitalization$787 thousandP/E Ratio-0.01Consensus RatingModerate BuyConsensus Price Target$3.00 (+7,592.3% Upside)Volume27.70 million sharesAverage Volume2.20 million shares14. Leafly NASDAQ:LFLY$0.20 0.00 (0.00%) As of 03/21/2025 03:59 PM EasternLeafly Holdings, Inc owns and operates a platform to provide consumers with cannabis information and connects consumers to cannabis brands and licensed retailers. More about LeaflyMarket Capitalization$618 thousandP/E Ratio-0.09Consensus RatingBuyConsensus Price Target$7.59 (+3,676.1% Upside)Volume522 sharesAverage Volume375,930 shares15. T2 Biosystems NASDAQ:TTOO$0.12 -0.01 (-6.40%) As of 03/21/2025 03:56 PM EasternT2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. More about T2 BiosystemsMarket Capitalization$2.46 millionConsensus RatingHoldConsensus Price Target$5.00 (+4,173.5% Upside)Volume49,389 sharesAverage Volume645,597 sharesToday's Range$0.11▼$0.1316. AIM ImmunoTech NYSE:AIM$0.14 +0.01 (+9.23%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$0.13 -0.01 (-6.34%) As of 03/21/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AIM ImmunoTech Inc, an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. More about AIM ImmunoTechMarket Capitalization$9.76 millionP/E Ratio-0.30Consensus RatingBuyConsensus Price Target$2.75 (+1,836.6% Upside)Volume331,798 sharesAverage Volume517,501 sharesRemove Ads17. Creative Media & Community Trust Co. NASDAQ:CMCT$0.25 -0.02 (-6.53%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$0.24 0.00 (-1.75%) As of 03/21/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Creative Media & Community Trust Corp. is a real estate investment trust that seeks to own, operate, and develop premier multifamily and creative office assets in vibrant and emerging communities throughout the United States. More about Creative Media & Community Trust Co.Market Capitalization$3.27 millionP/E Ratio-0.01Consensus RatingHoldConsensus Price Target$40.00 (+16,140.4% Upside)Volume409,661 sharesAverage Volume276,140 shares18. Ayr Wellness OTCMKTS:AYRWF$0.16 -0.01 (-4.08%) As of 03/21/2025 03:58 PM EasternAyr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. More about Ayr WellnessMarket Capitalization$18.85 millionP/E Ratio-0.07Consensus RatingModerate BuyConsensus Price Target$3.00 (+1,749.6% Upside)Volume744,481 sharesAverage Volume313,246 shares19. Cannabist OTCMKTS:CBSTF$0.04 0.00 (-1.98%) As of 03/21/2025 03:59 PM EasternThe Cannabist Company Holdings Inc engages in the cultivation, development, production, home delivery, and dispensary of cannabis products in the United States and internationally. More about CannabistConsensus RatingHoldVolume375,779 sharesAverage Volume945,037 sharesToday's Range$0.04▼$0.0550-Day Range$0.04▼$0.0752-Week Range$0.04▼$0.4420. TFF Pharmaceuticals NASDAQ:TFFP$0.06 0.00 (0.00%) As of 03/21/2025TFF Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. More about TFF PharmaceuticalsMarket Capitalization$289 thousandP/E Ratio-0.01Consensus RatingBuyConsensus Price Target$44.00 (+67,592.3% Upside)Average Volume598,067 sharesToday's Range$0.07▼$0.0721. MariMed OTCMKTS:MRMD$0.10 -0.01 (-6.43%) As of 03/21/2025 03:57 PM EasternMariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. More about MariMedMarket Capitalization$37.20 millionP/E Ratio-2.44Consensus RatingStrong BuyVolume831,249 sharesAverage Volume375,884 sharesToday's Range$0.10▼$0.1122. Viracta Therapeutics NASDAQ:VIRX$0.02 0.00 (-8.40%) As of 03/21/2025 03:54 PM EasternViracta Therapeutics, Inc, a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. More about Viracta TherapeuticsMarket Capitalization$910 thousandP/E Ratio-0.02Consensus RatingModerate BuyConsensus Price Target$4.05 (+17,585.6% Upside)Volume105,668 sharesAverage Volume1.08 million shares23. BIOLASE NASDAQ:BIOL$0.0076 +0.00 (+7.04%) As of 03/21/2025BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. More about BIOLASEMarket Capitalization$254 thousandP/E Ratio0.00Consensus RatingModerate BuyConsensus Price Target$1.20 (+15,689.5% Upside)Volume46,192 sharesAverage Volume2.58 million shares24. LuxUrban Hotels NASDAQ:LUXH$0.06 0.00 (-1.48%) As of 03/21/2025 03:54 PM EasternLuxUrban Hotels Inc utilizes an asset light business model to lease entire hotels on a long-term basis and rent out hotel rooms in the properties it leases. More about LuxUrban HotelsMarket Capitalization$163 thousandP/E Ratio0.00Consensus RatingHoldConsensus Price Target$280.00 (+466,566.7% Upside)Volume59,815 sharesAverage Volume323,056 shares25. Exro Technologies OTCMKTS:EXROF$0.07 0.00 (-2.72%) As of 03/21/2025 03:59 PM EasternExro Technologies Inc focuses on developing generation power-control electronics in Canada. The company offers Exro Coil Driver, which allows the motor to switch between different operational profiles in real-time, as well as have multiple gears for scooters, electric bikes, recreational, light electric cars, motorcycles, fleet vans, electric buses, passenger vehicles, long-haul trucks, and industrial vehicles markets; and Exro Cell Driver, a stationary energy storage system for commercial and industrial energy storage applications. More about Exro TechnologiesMarket Capitalization$39.34 millionP/E Ratio-0.14Consensus RatingHoldVolume91,735 sharesAverage Volume246,795 sharesToday's Range$0.07▼$0.08 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 03/17 - 03/21 FedEx Delivers Another Crushing Blow to Its Stock Price Micron Stock Will Retest All-Time Highs This Year Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge Could Palantir’s R1 Deal Be the Catalyst for a Stock Surge? BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock? Affirm Stock: Should You Buy the Dip After Walmart Setback? AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
